138 related articles for article (PubMed ID: 22593454)
21. Amelanotic vulvar melanoma: case report and review of the literature.
Baderca F; Cojocaru S; Lazăr E; Lăzureanu C; Lighezan R; Alexa A; Raica M; Nicola T
Rom J Morphol Embryol; 2008; 49(2):219-28. PubMed ID: 18516330
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of silver intensification of immunostaining for cytologic diagnosis of primary melanoma of the female genital organs.
Saito T; Takehara M; Tanaka R; Sato K; Fujita M; Kudo R
Acta Cytol; 2002; 46(6):1075-80. PubMed ID: 12462085
[TBL] [Abstract][Full Text] [Related]
23. Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.
Fagotti A; Petrillo M; Costantini B; Fanfani F; Gallotta V; Chiantera V; Turco LC; Bottoni C; Scambia G
Gynecol Oncol; 2014 Feb; 132(2):303-6. PubMed ID: 24378877
[TBL] [Abstract][Full Text] [Related]
24. The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.
Amit A; Hodes A; Lavie O; Keidar Z; Matanes E; Lowenstein L
Surg Oncol; 2017 Dec; 26(4):347-351. PubMed ID: 29113651
[TBL] [Abstract][Full Text] [Related]
25. Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer.
Arab M; Jamdar F; Sadat Hosseini M; Ghodssi- Ghasemabadi R; Farzaneh F; Ashrafganjoei T
Asian Pac J Cancer Prev; 2018 May; 19(5):1319-1324. PubMed ID: 29802693
[TBL] [Abstract][Full Text] [Related]
26. Unusual occurrence of a melanoma with intermixed epithelial component: a true melanocarcinoma?: case report and review of epithelial differentiation in melanoma by light microscopy and immunohistochemistry.
Wen YH; Giashuddin S; Shapiro RL; Velazquez E; Melamed J
Am J Dermatopathol; 2007 Aug; 29(4):395-9. PubMed ID: 17667176
[TBL] [Abstract][Full Text] [Related]
27. Amelanotic acral melanomas: clinicopathological, BRAF mutation, and KIT aberration analyses.
Choi YD; Chun SM; Jin SA; Lee JB; Yun SJ
J Am Acad Dermatol; 2013 Nov; 69(5):700-707. PubMed ID: 23972510
[TBL] [Abstract][Full Text] [Related]
28. Correspondence: Premature Stop of the SOCceR Trial, a Multicenter Randomized Controlled Trial on Secondary Cytoreductive Surgery: Netherlands Trial Register Number: NTR3337.
van de Laar R; Kruitwagen RF; Zusterzeel PL; Van Gorp T; Massuger LF
Int J Gynecol Cancer; 2017 Jan; 27(1):2. PubMed ID: 28002207
[No Abstract] [Full Text] [Related]
29. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
30. [Primary amelanotic malignant melanoma of the vagina--a case report].
Ikegaya H; Iwasaki T; Matsuda I; Satodate R; Sasou S
Gan No Rinsho; 1987 Oct; 33(12):1515-23. PubMed ID: 3316736
[TBL] [Abstract][Full Text] [Related]
31. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
[TBL] [Abstract][Full Text] [Related]
32. Molecular diagnosis in type I epithelial ovarian cancer.
Sadłecki P; Walentowicz-Sadłecka M; Grabiec M
Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228
[TBL] [Abstract][Full Text] [Related]
33. HMB-45 staining for cytology of primary melanoma of the vagina. A case report.
Takehara M; Ito E; Saito T; Nishioka Y; Ashihara K; Yamashita S; Koizumi M; Kudo R
Acta Cytol; 2000; 44(6):1077-80. PubMed ID: 11127738
[TBL] [Abstract][Full Text] [Related]
34. [Primary amelanotic meningeal melanomatosis].
Schulz C; Waldeck S
Fortschr Neurol Psychiatr; 2012 Jul; 80(7):402-6. PubMed ID: 22450762
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
[TBL] [Abstract][Full Text] [Related]
36. [Primary amelanotic anorectal melanoma--a case report].
Stroh C; Manger T
Zentralbl Chir; 2007 Dec; 132(6):560-3. PubMed ID: 18098086
[TBL] [Abstract][Full Text] [Related]
37. Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
Jamieson A; Sykes P; Eva L; Bergzoll C; Simcock B
Gynecol Oncol; 2017 Aug; 146(2):273-278. PubMed ID: 28549816
[TBL] [Abstract][Full Text] [Related]
38. Amelanotic malignant melanomas of the oral mucosa.
Notani K; Shindoh M; Yamazaki Y; Nakamura H; Watanabe M; Kogoh T; Ferguson MM; Fukuda H
Br J Oral Maxillofac Surg; 2002 Jun; 40(3):195-200. PubMed ID: 12054708
[TBL] [Abstract][Full Text] [Related]
39. Does Human Epididymis Protein 4 (HE4) Have a Role in Prediction of Recurrent Epithelial Ovarian Cancer.
Innao P; Pothisuwan M; Pengsa P
Asian Pac J Cancer Prev; 2016; 17(9):4483-4486. PubMed ID: 27797265
[TBL] [Abstract][Full Text] [Related]
40. Amelanotic melanoma of the oral cavity.
Chu L; Abdul A; Takahashi T; Kojima A; Himiya T; Kusama K; Komiyama K; Hori M; Matsumoto M; Tanaka H
J Nihon Univ Sch Dent; 1993 Jun; 35(2):124-9. PubMed ID: 8410206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
